Severe Burns News and Research

RSS

Phage therapy in conjunction with antibiotics could help treat dangerous bacterial infection

Yale researchers were fishing for a new weapon against antibiotic resistance and found one floating in a Connecticut pond, they report May 26, 2016 in the journal Scientific Reports.

26 May 2016

Small doses of cancer drug may be potential treatment for sepsis and other pandemics

Results from laboratory experiments and mouse studies suggest that small doses of drugs from a specific class of approved cancer medications called topoisomerase 1 (top1) inhibitors may protect against the overwhelming immune response to infection that sometimes leads to sepsis, a bacterial condition that kills as many as 500,000 people in the United States each year.

30 Apr 2016

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings, Inc., a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $3M investment from an institutional investor. Under the terms of the agreement, the investor will be issued $3.3M worth of Series H Convertible Preferred Stock (including 10% original issue discount) from the Company and five year warrants exercisable for 13,200,000 shares of common stock at $0.40 per share.

22 Feb 2016

Simulated practice in healthcare: an interview with Andy Anderson

There's around 95 to 100 simulation centres across the NHS in secondary care. These centres are used for a whole variety of training, practicing of skills and recreating incidents so that staff can prevent them recurring.

10 Feb 2016

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Amarantus BioScience Holdings, Inc., a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the US Food and Drug Administration to treat GCMN with Engineered Skin Substitute (ESS).

30 Dec 2015

AlloSource receives two patents for cartilage repair allografts

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, received two patents from the United States Patent and Trademark Office for cartilage repair allografts.

29 Dec 2015

AlloSource expands wound care portfolio with new US patent for novel dermal allograft

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, has been granted a patent for an acellular human dermal matrix processed to be delivered via syringe.

23 Dec 2015

New combination treatment provides better wound healing compared to SSGs alone

The use of meshed split skin autographs (SSGs) is a standard treatment for large, deep burns. However, serious scarring is often a result. In an effort to improve wound healing and reduce scarring, a team of researchers in The Netherlands tested a treatment technique on patients with serious, deep burns that employed SSGs along with autologous cultured proliferating epidermal cells (ECs) compared to SSGs alone.

3 Nov 2015

Nutrition vital for patients recovering from severe burns

For someone recovering from severe burns, eating is often the last thing they want to do. However, burn specialists at The Ohio State University Wexner Medical Center say nutrition is so vital to their patients' recovery that they make it a quality indicator for patient care.

24 Jul 2015

Severe burns dramatically change bacteria populations, study finds

A study published in PLOS ONE has found that burn patients experience dramatic changes in the 100 trillion bacteria inside the gastrointestinal tract.

9 Jul 2015

Cell transplantation researchers successfully treat laboratory rats modeled with severe burns

Cell transplantation researchers have successfully used bone marrow-derived mesenchymal stromal cells (MSCs) to treat a variety of diseases and conditions. Now, using injections of MSCs, a research team in Brazil has successfully treated laboratory rats modeled with severe burns.

25 Jun 2015

AlloSource's AlloWrap DS amniotic membrane moved to high-cost reimbursement category

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that AlloWrap DS, its double-sided human amniotic membrane allograft, has been moved to the high-cost reimbursement category.

29 May 2015

AlloSource recognized with CBSA's Company of the Year award

AlloSource, one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, has been named the Company of the Year by the Colorado BioScience Association. AlloSource is a repeat winner, having won this award in 2007.

7 Nov 2014

AlloSource receives wellness awards from Cigna and Denver Business Journal

AlloSource, one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, received a pair of wellness awards from Cigna and the Denver Business Journal.

26 Jul 2014

Doctor offers tips on fireworks safety to prevent injuries

Fireworks can result in severe burns, scars and disfigurement that can last a lifetime. Fireworks that are often thought to be safe, such as sparklers, can reach temperatures above 2000 degrees Fahrenheit, and can burn users and bystanders.

1 Jul 2014

Researchers engineer skin cells for first time containing blood and lymphatic capillaries

Researchers at the University Children's Hospital Zurich and the University of Zurich have engineered skin cells for the very first time containing blood and lymphatic capillaries. They succeeded in isolating all the necessary types of skin cells from human skin tissue and engineering a skin graft that is similar to full-thickness skin.

30 Jan 2014

UCLA launches first university-based military medicine center to care for wounded veterans

UCLA has launched the first university-based military medicine center on the West Coast, thanks to a generous donation from two sons in honor their father, the inventor, entrepreneur and philanthropist Ronald A. Katz.

7 Nov 2013

Mayo Clinic provides tips to stay safe this summer

A backyard fireworks display may look pretty and get family and friends excited, but when it comes to lighting fireworks, leave it to the professionals, Mayo Clinic physicians are advising. Each year, Mayo Clinic doctors see dozens of patients who have lost fingers and limbs, gotten severe burns and suffered hearing loss as a direct result of using fireworks. Even seemingly harmless fireworks - such as sparklers - can cause severe burns and even blindness.

2 Jul 2013

Sterling Insurance increases availability of Sterling Critical Condition to 31 states

Sterling Insurance is proud to announce the expansion of Sterling Critical Condition in 18 additional states, increasing the availability to 31 states.

15 May 2013

New challenges to military medicine

Better body armor and rapid aeromedical evacuations enable American service members to survive blasts that would have proved fatal in Vietnam or even the first Gulf War, but they pose new challenges to military medicine - how to deal with the excruciating pain of injuries, especially severe burns from IED blasts that body armor can't protect.

13 May 2013